AlphaBet: A Phase I/II Trial Evaluating the Combination of Radium-223 and [177Lu]lu-Psma-i&t in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Metastatic Prostate Cancer,Alpha Particle Therapy,Prostate Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined